BONACINA, FABRIZIA
BONACINA, FABRIZIA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies
2024 F. Bonacina, D. Della-Morte
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity
2024 M. Svecla, L. Da Dalt, A. Moregola, J. Nour, A. Baragetti, P. Uboldi, E. Donetti, L. Arnaboldi, G. Beretta, F. Bonacina, G.D. Norata
Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanisms
2023 E. Osto, F. Bonacina, A. Pirillo, G.D. Norata
Gonadal sex vs genetic sex in experimental atherosclerosis
2023 J. Nour, F. Bonacina, G.D. Norata
Fibronectin extra domain a limits liver dysfunction and protects mice during acute inflammation
2023 V.K.P. Venu, A. Moregola, L. Da Dalt, P. Uboldi, F. Bonacina, A.F. Muro, G.D. Norata
Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet-induced obesity
2023 R. Bellini, A. Moregola, J. Nour, P. Uboldi, F. Bonacina, G.D. Norata
The heterogeneous cellular landscape of atherosclerosis: Implications for future research and therapies. A collaborative review from the EAS young fellows
2023 F. Bonacina, A. Di Costanzo, V. Genkel, X.Y. Kong, J. Kroon, E. Stimjanin, D. Tsiantoulas, M.O. Grootaert
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression
2023 R. Bellini, A. Moregola, J. Nour, Y. Rombouts, O. Neyrolles, P. Uboldi, F. Bonacina, G.D. Norata
The glucose transporter 2 regulates CD8+ T cell function via environment sensing
2023 H. Fu, J. Vuononvirta, S. Fanti, F. Bonacina, A. D'Amati, G. Wang, T. Poobalasingam, M. Fankhaenel, D. Lucchesi, R. Coleby, D. Tarussio, B. Thorens, R.J. Hearnden, M.P. Longhi, P. Grevitt, M.H. Sheikh, E. Solito, S.A. Godinho, M. Bombardieri, D.M. Smith, D. Cooper, A.J. Iqbal, J.C. Rathmell, S. Schaefer, V. Morales, K. Bianchi, G.D. Norata, F.M. Marelli-Berg
Role of histone deacetylase 3 (HDAC3) in adipose tissue metabolism and immunophenotype
2022 L. Coppi, C. Peri, F. Bonacina, R. Longo, D. Cricrí, S. Pedretti, R. Silva, I. Severi, A. Giordano, G. Danilo Norata, A.L. Catapano, N. Mitro, E.S.R. DE FABIANI, M. Crestani
Monocarboxylate transporter 1 deficiency impacts CD8+ T lymphocytes proliferation and recruitment to adipose tissue during obesity
2022 C. Macchi, A. Moregola, M.F. Greco, M. Svecla, F. Bonacina, S. Dhup, R.K. Dadhich, M. Audano, P. Sonveaux, C. Mauro, N. Mitro, M. Ruscica, G.D. Norata
The low-density lipoprotein receptor-mTORC1 axis coordinates CD8+ T cell activation
2022 F. Bonacina, A. Moregola, M. Svecla, D. Coe, P. Uboldi, S. Fraire, S. Beretta, G. Beretta, F. Pellegatta, A.L. Catapano, F.M. Marelli-Berg, G.D. Norata
Loss of voltage-gated hydrogen channel 1 expression reveals heterogeneous metabolic adaptation to intracellular acidification by T cells
2022 D. Coe, T. Poobalasingam, H. Fu, F. Bonacina, G. Wang, V. Morales, A. Moregola, N. Mitro, K.C. Cheung, E.J. Ward, S. Nadkarni, D. Aksentijevic, K. Bianchi, G.D. Norata, M. Capasso, F.M. Marelli-Berg
Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity
2022 J. Nour, A. Moregola, M. Svecla, L. Da Dalt, R. Bellini, O. Neyrolles, G.P. Fadini, Y. Rombouts, M. Albiero, F. Bonacina, G.D. Norata
Genetically determined hypercholesterolaemia results into premature leucocyte telomere length shortening and reduced haematopoietic precursors
2022 A. Baragetti, F. Bonacina, L. Da Dalt, A. Moregola, V. Zampoleri, F. Pellegatta, L. Grigore, A. Pirillo, R. Spina, A.B. Cefalù, M. Averna, G.D. Norata, A.L. Catapano
Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance
2022 R. Bellini, F. Bonacina, G.D. Norata
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis
2022 A. Marku, L. Da Dalt, A. Galli, N. Dule, P. Corsetto, A.M. Rizzo, A. Moregola, P. Uboldi, F. Bonacina, P. Marciani, M. Castagna, A.L. Catapano, G.D. Norata, C. Perego
Rupatadine treatment is associated to atherosclerosis worsening and altered T lymphocyte recruitment
2022 M. Busnelli, S. Manzini, A. Colombo, F. Bonacina, G.D. Norata, E. Franchi, S. Castiglioni, C. Andronis, E. Lekka, E. Scanziani, G. Chiesa
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia
2022 M. Busnelli, S. Manzini, A. Colombo, E. Franchi, F. Bonacina, M. Chiara, F. Arnaboldi, E. Donetti, F. Ambrogi, R. Oleari, A. Lettieri, D. Horner, E. Scanziani, G.D. Norata, G. Chiesa
Il trattamento con rupatadina in topi knockout per apolipoproteina e è associato a un peggioramento dell’aterosclerosi e a un alterato reclutamento dei linfociti T
2021 E. Franchi, M. Busnelli, S. Manzini, A. Colombo, F. Bonacina, G.D. Norata, S. Castiglioni, C. Andronis, E. Lekka, E. Scanziani, G. Chiesa